Luo Yan, Bian Ce
Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Front Oncol. 2022 Sep 14;12:962613. doi: 10.3389/fonc.2022.962613. eCollection 2022.
Pure primary ovarian squamous cell carcinoma (oSCC) is very rare, with about 42 cases have been reported in the literature. Lacking effective treatment guidelines, the prognosis of oSCC is extremely poor. Here, we report a 52-year-old postmenopausal woman diagnosed with pure primary oSCC in our center. The patient received debulking surgery followed by chemotherapy with carboplatin, paclitaxel, and bevacizumab. The patient survived 11 months after surgery and died of tumor progression and multiple organ failure. We also present a review of the literature.
纯原发性卵巢鳞状细胞癌(oSCC)非常罕见,文献中报道的病例约有42例。由于缺乏有效的治疗指南,oSCC的预后极差。在此,我们报告一名52岁的绝经后女性,在我们中心被诊断为纯原发性oSCC。该患者接受了肿瘤细胞减灭术,随后接受了卡铂、紫杉醇和贝伐单抗化疗。患者术后存活了11个月,最终死于肿瘤进展和多器官功能衰竭。我们还对相关文献进行了综述。